Emergent BioSolutions Inc. (EBS) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization Margin | 23.00 percent | FY2026-Q1 |
| Adjusted Gross Margin Percentage | 52.00 percent | FY2026-Q1 |
| Adjusted Net Income Per Diluted Share | 0.21 USD_per_share | FY2026-Q1 |
| Adjusted Net Income (Loss) | -22.7M | FY2025-Q4 |
| Adjusted Net Income (Loss) Per Diluted Share | -0.43 USD_per_share | FY2025-Q4 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization | 28.5M | FY2025-Q2 |
| Commercial Products Adjusted Gross Margin Percentage | 46.00 percent | FY2025-Q1 |
Back to EBS overview · EBS earnings · EBS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.